Insider Transactions in Q2 2022 at Regenxbio Inc. (RGNX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2022
|
Olivier Danos Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
728
+0.77%
|
$15,288
$21.0 P/Share
|
|
Jun 03
2022
|
Jean Bennett |
BUY
Grant, award, or other acquisition
|
Direct |
3,010
+50.0%
|
-
|
|
Jun 03
2022
|
Allan M. Fox |
BUY
Grant, award, or other acquisition
|
Direct |
3,010
+50.0%
|
-
|
|
Jun 03
2022
|
Alexandra Glucksmann |
BUY
Grant, award, or other acquisition
|
Direct |
3,010
+50.0%
|
-
|
|
Jun 03
2022
|
Argeris N Karabelas |
BUY
Grant, award, or other acquisition
|
Direct |
3,010
+50.0%
|
-
|
|
Jun 03
2022
|
George V Migausky |
BUY
Grant, award, or other acquisition
|
Direct |
3,010
+50.0%
|
-
|
|
Jun 03
2022
|
David C Stump |
BUY
Grant, award, or other acquisition
|
Direct |
3,010
+50.0%
|
-
|
|
Jun 03
2022
|
Daniel Tasse |
BUY
Grant, award, or other acquisition
|
Direct |
3,010
+50.0%
|
-
|
|
Jun 03
2022
|
Jennifer Zachary |
BUY
Grant, award, or other acquisition
|
Direct |
6,020
+50.0%
|
-
|